Oncology & Cancer

Starving cancer cells of sugar—does it work?

Previous research have shown that rapidly dividing cancer cells require higher levels of sugar than healthy cells. This dependency on sugar distinguishes cancer cells from normal cells and is often used as a treatment option ...

Oncology & Cancer

Study casts doubt on impact of menthol-flavored tobacco ban

A ban on the sale of menthol-flavored cigarettes that the U.S. Food and Drug Administration (FDA) is on track to implement may have unintended consequences, according to a study by researchers from Vanderbilt University Medical ...

Oncology & Cancer

Benefits of prostate-specific antigen testing remain unclear

(HealthDay) -- It remains unclear whether the benefits of prostate-specific antigen (PSA) testing outweigh the harms, but evidence suggests that men with a longer life expectancy may benefit from testing, according to a provisional ...

Oncology & Cancer

With breast cancer risks, where you live matters, researchers find

Inadequate health care access, unhealthy diets and not enough exercise are all well-known risk factors for the number one cause of cancer-related deaths in women—breast cancer—but what was never clear is why death rates ...

Medications

Promising approach against treatment-resistant cancer

As described in the March 7 issue of Nature Communications, investigators used a two-drug combination to achieve chemotherapy's goal: to make cancer cells self-destruct via the biological process known as apoptosis, often ...

Oncology & Cancer

Poor diet may spur inflammation-related health problems

(HealthDay)—People with diets that promote inflammation—such as those high in sugar and saturated fats—are at increased risk for early death from all causes, including gastrointestinal tract cancers, a new study suggests.

Oncology & Cancer

Potential treatment target for KRAS-mutated colon cancer found

Researchers from the Massachusetts General Hospital (MGH) Cancer Center have identified a new potential strategy for treating colon tumors driven by mutations in the KRAS gene, which usually resist both conventional and targeted ...

page 7 from 40